FCM
ADAP

Farallon Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Farallon Capital Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
2020
Q3 		$20.1M Buy
2020
Q2 		$25M Buy
2015
Q3 		– Sell
2015
Q2 		$4.58M Buy